Latest Ratings for DECK Date Firm Action From To Feb 2022 Telsey Advisory Group Maintains Outperform Jan 2022 Seaport Global Initiates Coverage On Buy Oct 2021 Wedbush Initiates Coverage On Neutral View More Analyst Ratings for DECK View the Latest Analyst Ratings read more
Latest Ratings for PLUG Date Firm Action From To Mar 2022 Canaccord Genuity Maintains Hold Mar 2022 JP Morgan Maintains Overweight Mar 2022 RBC Capital Maintains Outperform View More Analyst Ratings for PLUG View the Latest Analyst Ratings read more
Latest Ratings for PLAY Date Firm Action From To Jan 2022 Gordon Haskett Upgrades Hold Buy Dec 2021 Truist Securities Maintains Buy Oct 2021 Loop Capital Initiates Coverage On Buy View More Analyst Ratings for PLAY View the Latest Analyst Ratings read more
Latest Ratings for DD Date Firm Action From To Feb 2022 Keybanc Maintains Overweight Feb 2022 Credit Suisse Maintains Outperform Feb 2022 Mizuho Maintains Buy View More Analyst Ratings for DD View the Latest Analyst Ratings read more
Latest Ratings for AME Date Firm Action From To Jan 2022 Morgan Stanley Maintains Overweight Dec 2021 Mizuho Initiates Coverage On Buy Dec 2021 Wolfe Research Upgrades Peer Perform Outperform View More Analyst Ratings for AME View the Latest Analyst Ratings read more
As long as cannabis is classified a Schedule I substance, banks are prohibited from dealing with the industry’s billions of dollars. read more
Tesla FSD and robotaxi opportunities are highlighted by an analyst in a new report with robotaxi revenue estimates for 2027 listed. Latest Ratings for TSLA Date Firm Action From To Feb 2022 Daiwa Capital Upgrades Neutral Outperform Feb 2022 Piper Sandler Maintains Overweight Jan 2022 Credit Suisse Upgrades Neutral Outperform View More Analyst Ratings for…
Humana shares are trading lower by 3.7% during Thursday’s session. Shares are lower following UnitedHealth Group’s earnings report, reflecting concerns about potential impacts on peers. read more